Current autologous transfusion practices. Implications for the future.

Abstract

A questionnaire was distributed to 509 AABB institutional members to evaluate current autologous transfusion practices. Results were returned from 47 blood centers, 108 transfusion services and 64 hospital blood banks (response rate 43%). Results indicate that not all eligible patients are allowed to donate due to unnecessarily strict eligibility criteria. Thirty percent of autologous units are not tested for infectious disease markers. Of those units tested and found positive for anti-HIV or HBsAg, 53 and 72% respectively, of the institutions provide the units to the intended recipient. Forty-seven percent of institutions perform an AHG crossmatch for autologous recipients. Sixty five percent of institutions permit "crossing-over" of autologous units for homologous use. Implications of these findings for the development of standards for autologous transfusion programs are discussed.